SOLICITATION NOTICE
A -- RAPID HIV POINT-OF-CARE DIAGNOSTIC DEVICE FOR RESOURCE-LIMITED SETTINGS
- Notice Date
- 7/17/2008
- Notice Type
- Presolicitation
- NAICS
- 541712
— Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Office of Acquisitions, 6700 B Rockledge Room 3214 MSC7612, Bethesda, Maryland, 20892-7612
- ZIP Code
- 20892-7612
- Solicitation Number
- NIH-NIAID-DAIDS-BAA-NIHAI2008027
- Archive Date
- 12/3/2008
- Point of Contact
- Cecil Butler,, Phone: 301-496-0612
- E-Mail Address
-
butlerce@mail.nih.gov
- Small Business Set-Aside
- N/A
- Description
- This BAA solicitation seeks the development of a rapid HIV point-of-care diagnostic device for resource-limited settings (hereinafter referred to as rapid virus test.) The National Institute of Allergies and Infectious Diseases (NIAID) seeks to fund a consortium of scientists, possessing a breadth of complementary skills and expertise in clinical HIV research. The consortium should additionally possess expertise with associated molecular technology, diagnostics, validation testing, GMP manufacturing, and project management, with the goal of developing a simple to use, rapid, point-of-care (POC) HIV diagnostic device. The device should possess candidate vaccine constructs and developed vaccine-induced antibodies in the absence of true HIV-1 infections and HIV-infected infants. The diagnostic technology must demonstrate feasibility for use in resource-limited settings and in POC clinics without the use of supporting laboratory equipment. Examples of such equipment are centrifuges, vortexes and pipettes. In addition, if proposed testing requires processing of patient samples for downstream applications, the processing must be self- contained, and require limited sample manipulation, and provide safe containment of potentially infectious material. The optimal format is visual, without ambiguity, and includes a full process for negative and internal positive control. It is anticipated that 1 to 2 cost reimbursement, completion type contracts will be awarded on or about August 3, 2009 for a period of five years for the base period and options in years 3 and 4 for additional services; studies for a similar device to make limited treatment decisions based on viral load. NIAID-DAIDS-BAA-NIHAI2008027 will be available electronically on or about August 1, 2008, and may be accessed through FedBizOpps at http://www.fedbizopps.gov/. This advertisement does not commit the Government to award a contract. All responsible sources may submit a proposal which will be considered by the agency. No collect calls will be accepted. No facsimile transmissions will be accepted.
- Web Link
-
FedBizOpps Complete View
(https://www.fbo.gov/?s=opportunity&mode=form&id=4c2178564bded9d9f215d0b79afa2655&tab=core&_cview=1)
- Place of Performance
- Address: Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Office of Acquisitions, 6700-B Rockledge Drive, Room 3214, MSC 7612, Bethesda, MD, 20892-7612, Bethesda, Maryland, 20892, United States
- Zip Code: 20892
- Zip Code: 20892
- Record
- SN01616336-W 20080719/080717220452-4c2178564bded9d9f215d0b79afa2655 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |